Image

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Investigational PET Imaging for Cancer Detection

Recruiting
18-120 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates cancer detection using a new type of PET imaging called [18F]FAPI-74. The purpose of this study is to explore its effectiveness in identifying certain types of cancer.

The study focuses on evaluating the ability of [18F]FAPI-74 PET imaging to detect cancer compared to other standard imaging methods. Researchers are interested in seeing if this investigational imaging method can provide better visualization of tumors.

  • Who can participate: Adults aged 18 or older with specific types of cancer such as pancreatic, liver, or ovarian cancer may participate. Participants must be scheduled for cancer treatment and meet certain health criteria.
  • Study details: Participants will undergo PET imaging using [18F]FAPI-74, which involves a tracer injected into the body before scanning.
  • Study timelines: The study will last 2 years.
Print
Study details
    Sarcoma
    Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC)
    Mesothelioma
    Pheochromocytoma/Paraganglioma (PPGL)
    Pancreatic Ductal Adenocarcinoma
    Ovarian Cancer
    Hepatocellular Carcinoma
    Gastric Cancer
    Cholangiocarcinoma
    Bladder Cancer

NCT06503146

National Cancer Institute (NCI)

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.